Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats

被引:0
|
作者
Chun-Jie Liu
机构
关键词
Keratinocyte growth factor; Ulcerative colitis; Gene therapy; Attenuated Salmonella typhimurium;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate the effect of keratinocyte growth factor(KGF) gene therapy in acetic acid-induced ulcerative colitis in rat model.METHODS:The colitis of Sprague-Dawley rats was induced by intrarectal infusion of 1 mL 5%(v/v) acetic acid.Twenty-four hours after exposed to acetic acid,rats were divided into three experimental groups:control group,attenuated Salmonella typhimurium Ty21a strain(SP) group and SP strain carrying human KGF gene(SPK) group,and they were separately administered orally with 10% NaHCO3,SP or SPK.Animals were sacrificed and colonic tissues were harvested respectively on day 3,5,7 and 10 after administration.Weights of rats,colonic weight/length ratio and stool score were evaluated.Histological changes of colonic tissues were examined by hematoxylin and eosin(HE) staining method.The expression of KGF,KGF receptor(KGFR) and TNF-α were measured either by enzyme-linked immunosorbent assay or Western blotting.Immunohistochemistry was used to detect the cellular localization of KGFR and Ki67.In addition,superoxide dismutase(SOD) activity and malondialdehyde(MDA) contents in the homogenate were measured.RESULTS:Body weight and colonic weight/length ratio were declined in SPK group compared with SP and control groups(body weight:272.78 ± 17.92 g vs 243.72 ± 14.02 g and 240.68 ± 12.63 g,P < 0.01;colonic weight/length ratio:115.76 ± 7.47 vs 150.32 ± 5.99 and 153.67 ± 5.50 mg/cm,P < 0.01).Moreover,pathological changes of damaged colon were improved in SPK group as well.After administration of SPK strain,KGF expression increased markedly from the 3rd d,and remained at a high level till the 10th d.Furthermore,KGFR expression and Ki67 expression elevated,whereas TNF-α expression was inhibited in SPK group.In the group administered with SPK,SOD activity increased significantly(d 5:26.18 ± 5.84 vs 18.12 ± 3.30 and 18.79 ± 4.74 U/mg,P < 0.01;d 7:35.48 ± 3.35 vs 22.57 ± 3.44 and 21.69 ± 3.94 U/mg,P < 0.01;d 10:46.10 ± 6.23 vs 25.35 ± 4.76 and 27.82 ± 6.42 U/mg,P < 0.01) and MDA contents decreased accordingly(d 7:7.40 ± 0.88 vs 9.81 ± 1.21 and 10.45 ± 1.40 nmol/mg,P < 0.01;d 10:4.36 ± 0.62 vs 8.41 ± 0.92 and 8.71 ± 1.27 nmol/mg,P < 0.01),compared with SP and control groups.CONCLUSION:KGF gene therapy mediated by attenuated Salmonella ameliorates ulcerative colitis induced by acetic acids,and it may be a safe and effective treatment for ulcerative colitis.
引用
收藏
页码:2632 / 2640
页数:9
相关论文
共 50 条
  • [41] Immunosuppressive and biologic therapy for ulcerative colitis
    Ardizzone, Sandro
    Cassinotti, Andrea
    de Franchis, Roberto
    EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (04) : 449 - 467
  • [42] SURGICAL THERAPY IN ULCERATIVE-COLITIS
    RUF, G
    FARTHMANN, EH
    MEDIZINISCHE WELT, 1993, 44 (03): : 200 - 206
  • [43] Medical Therapy of Active Ulcerative Colitis
    Buerger, Martin
    Schmidt, Carsten
    Teich, Niels
    Stallmach, Andreas
    VISZERALMEDIZIN, 2015, 31 (04): : 236 - 244
  • [44] MEDICAL THERAPY OF ULCERATIVE-COLITIS
    GENDRE, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (2TER): : T9 - &
  • [45] Maintenance therapy options for ulcerative colitis
    Chaparro, Maria
    Gisbert, Javier P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1339 - 1349
  • [46] Biological therapy for ulcerative colitis: An update
    Seo, Geom Seog
    Chae, Soo-Cheon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (37) : 13234 - 13238
  • [47] Biological therapy for ulcerative colitis:An update
    Geom Seog Seo
    Soo-Cheon Chae
    World Journal of Gastroenterology, 2014, (37) : 13234 - 13238
  • [48] Mesalamine in the Initial Therapy of Ulcerative Colitis
    Chibbar, Richa
    Moss, Alan C.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (04) : 689 - +
  • [49] Jianpi Bushen Qingchang Huashi Recipe Ameliorates Ulcerative Colitis in Rats by Regulating Gut Microbiota and Bile Acid
    Zhao, Song
    Xu, Yi
    Zhu, Lei
    Feng, Wan
    Zhang, Lu
    Xu, LuZhou
    Shen, Hong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (04): : 995 - 1005
  • [50] GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR GENE THERAPY AMELIORATES CHRONIC HYPERPROLACTINEMIA IN SENILE RATS
    Morel, G. R.
    Sosa, Y. E.
    Bellini, M. J.
    Carri, N. G.
    Rodriguez, S. S.
    Bohn, M. C.
    Goya, R. G.
    NEUROSCIENCE, 2010, 167 (03) : 946 - 953